| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850517 | American Journal of Kidney Diseases | 2009 | 8 Pages |
Abstract
This study suggests that the risk of vascular access failure may be greater with subcutaneous compared with intravenous administration of EPO in hemodialysis patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Young-Ki MD, Ja-Ryong MD, Jin-Kyung MD, In-Il MD, Min-Ha MD, Jong-Woo MD, Jung-Woo MD, Nosratola D. MD,